- The role of the pharmacist in optimizing the use of erythropoietin stimulating agentsShereen Nabhani Gebara
School of Pharmacy and Chemistry, Kingston University, Penrhyn Road, Kingston upon Thames KT1 2EE, UK
J Oncol Pharm Pract 16:33-7. 2010..This review explores the benefits and risks linked to ESAs use, and the proposed role...
- Risk of osteonecrosis of the jaw in cancer patients taking bisphosphonatesShereen Nabhani Gebara
School of Pharmacy and Chemistry, Kingston University, Kingston KT1 2EE, United Kingdom
Am J Health Syst Pharm 66:1541-7. 2009..The risk of osteonecrosis of the jaw (ONJ) associated with bisphosphonate use in patients with cancer is reviewed...